NewslettersHematopoiesis NewsUncategorizedLow NCOR2 Levels in Multiple Myeloma Patients Drive Multidrug Resistance via MYC UpregulationBy Justin.choi - December 7, 2021011To define the role of NCOR2 in multiple myeloma, the authors created NCOR2 knockout human myeloma cell lines and demonstrated that NCOR2 knockout led to high MYC expression.[Blood Cancer Journal] 6445212 BBBBBBBB items 1 apa 0 default asc 1 169800 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article